Discontinuation report HYTRIN
Report ID | 8396 |
Drug Identification Number | 00818666 |
Brand name | HYTRIN |
Common or Proper name | Hytrin |
Company Name | BGP PHARMA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TERAZOSIN HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04CA |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-04-24 |
Remaining supply date | 2017-03-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-28 | English | Compare |
v2 | 2017-04-28 | English | Compare |
v3 | 2017-04-28 | French | Compare |
Showing 1 to 3 of 3